"PHA's research program has yielded an explosion of understanding about PH that was not known before." – John Newman, MD, Vanderbilt University Medical Center

Twenty years ago there were no pulmonary hypertension treatments available. Through focused research there are now twelve PH-specific treatments with more in development. But we know that your ultimate wish is for a cure, and that is why PHA will continue to support the work of researchers until the day when no one suffers from PH.

PHA’s Research Program

PHA's Research Program has committed more than $15 million for PH research by leveraging partnerships with the National Heart, Lung, and Blood Institute (NHLBI) and the American Thoracic Society (ATS). We have supported 70 promising researchers through four independently reviewed, cutting-edge research programs.

PH Treatments: What's on the Horizon

View a recording of a May 2015 webinar in which Dr. Ioana Preston of Tufts Medical Center covers the current treatments available for PH as well as new treatments in the pipeline.

Current Treatments

PHA’s Scientific Leadership Council’s Education Committee has put together comprehensive fact sheets on all the treatments available for pulmonary hypertension.

Research Corner in Pathlight

Every issue of Pathlight, PHA’s quarterly magazine, features a Research Corner with information about some of the latest research.

FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2015 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.